Composition, form of production and packaging
? Nasal drops in the form of a clear liquid from blue to green-blue, with a menthol-eucalyptus odor.
10 g (1 fl.)
pine-tree oil 375.2 mg
eucalyptus oil 50 mg
Thymol 3.2 mg
? -tocopherol acetate 170 mg
peppermint oil 100 mg
guayazulene 2 mg
Auxiliary substances: butylhydroxyanisole, macrogol and glyceride esters of apricot oil (Labrafil M-1944-CS), vegetable oil.
10 ml - bottles of brown glass with a rubber pipette with a lid (1) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2016.
An anticongestive agent of plant origin. Has anti-inflammatory and antiseptic effect.
Data on the pharmacokinetics of Pinosol В® are not available.
- Acute rhinitis;
- chronic atrophic rhinitis;
- acute and chronic inflammatory diseases of the mucous membranes of the nose and nasopharynx, accompanied by dry mucous membranes of the nose;
- condition after surgery in the nasal cavity - as prescribed by the doctor (in a hospital and outpatient setting).
Adults on the first day of the drug instill 1-2 drops in each nasal passage with an interval of 1-2 hours. In the following days - 1-2 drops in each nasal passage 3-4 times / day.
Children are instilled 1-2 drops 3-4 times / day or use a cotton swab.
It is possible to use the drug in the form of inhalations, which should be carried out with the aid of an inhaler. For this, 2 ml (50 drops) is instilled in the inhaler;multiplicity of application - 2-3 times / day.
Duration of treatment is 5-7 days.
Local reactions: itching, burning sensation, hyperemia and edema of the nasal mucosa.
- Allergic rhinitis;
- Children under 2 years;
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
Possible use of the drug Pinosol В® during pregnancy and lactation (breastfeeding) according to the indications.
APPLICATION FOR CHILDREN
Children over 2 years instilled 1-2 drops 3-4 times / day or use a cotton swab.
If there are undesirable phenomena or other unusual reactions not described in the instructions, the patient should consult a doctor.
To date, cases of overdose of Pinosol В® have not been observed.
Drug interaction of the preparation Pinosol В® is not described.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a dry, protected from light, out of reach of children at a temperature of 15 В° to 25 В° C. Shelf life - 3 years.